O'Shaughnessy Asset Management’s AngioDynamics ANGO Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,029	Closed	-$27K	–	1312
2021 Q3	$27K	Buy	1,029 +187	+22%	+$5K	﹤0.01%	1840
2021 Q2	$23K	Buy	+842	New	+$20.6K	﹤0.01%	1797
2017 Q4	–	Sell	-15,302	Closed	-$262K	–	921
2017 Q3	$262K	Sell	15,302 -80,786	-84%	-$1.36M	0.01%	472
2017 Q2	$1.56M	Sell	96,088 -10,061	-9%	-$159K	0.04%	238
2017 Q1	$1.84M	Sell	106,149 -4,872	-4%	-$81.5K	0.04%	220
2016 Q4	$1.87M	Buy	111,021 +20,126	+22%	+$336K	0.04%	216
2016 Q3	$1.59M	Buy	+90,895	New	+$1.47M	0.04%	225

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

O'Shaughnessy Asset Management's ANGO Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of AngioDynamics (ANGO) in Q4 2021, closing a stake of 1,029 shares — an estimated $27K sold.

O'Shaughnessy Asset Management first reported a position in ANGO in Q3 2016 and held it in 7 quarters. The position peaked at $1.87M in Q4 2016. 170 funds tracked by Wall St. Rank hold ANGO as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining AngioDynamics position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 1,029 AngioDynamics shares in Q4 2021, an estimated $27K.
O'Shaughnessy Asset Management first reported a position in AngioDynamics in Q3 2016 and held it in 7 quarters.
O'Shaughnessy Asset Management's AngioDynamics position peaked at $1.87M in Q4 2016.
170 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.